Elekta recently announced that it will purchase Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio. Financial terms of the deal were not disclosed in the May 3 news release. Stockholm-based Elekta said the deal bolsters its position in treatment planning as it seeks to be the innovation leader in radiation therapy. By integrating the […]
Elekta
GE HealthCare adds MIM Software to Elekta collaboration
GE HealthCare announced today that it expanded its relationship with Elekta with more collaboration on software for radiation oncology. Together, the companies aim to accelerate innovation in software to improve workflows, increase throughput and enhance user experience. They expect to enable greater precision in radiation therapy treatment with less time at the hospital for patients. […]
Elekta receives $40M radiation tech order in India
Elekta announced today that it received an order worth approximately $40 million for its full suite of hardware and software. Stockholm, Sweden-based Elekta develops precision radiation therapy to treat cancer. The FDA cleared its latest offering, the Comprehensive Motion Management (CMM) with True Tracking and automatic gating, earlier this year. Krishna Institute of Medical Sciences […]
iCad sells Xoft brachytherapy business to Elekta
iCad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million. Elekta is taking over the business, effective immediately, and will make final payments to iCad no later than November 6, 2023. As part of the deal, Elekta will assume all liabilities, and employees will transfer with the business. The […]
Elekta forms radiotherapy partnership with Sinopharm in China
Elekta announced today that it entered into a joint venture with Sinopharm to increase the adoption of radiation therapy in China. The initiative aims to bring radiation therapy to what’s considered lower-tier cities. These cities comprise approximately 70% of China’s population, according to a news release. Elekta develops precision radiation therapy to treat cancer. The […]
FDA clears Elekta’s radiation therapy automation
Elekta (Stockholm:EKTA-B) says an FDA 510(k) clearance represents a new era in precision radiation therapy to treat cancer in the U.S. The Sweden-based cancer and brain treatment tech company announced today that the FDA has cleared Comprehensive Motion Management (CMM) with True Tracking and automatic gating. The features are part of Elekta’s Unity MR-Linac radiotherapy […]
Elekta launches its Elekta Esprit radiosurgery system
Elekta (KTA-B.ST) announced today that it launched its Espirit automated treatment planning system. Stockholm, Sweden-based Elekta designed its latest and most advanced system to offer significantly faster, automated treatment planning for clinicians, with more personalized and patient-friendly treatments and a degree of precision capable of protecting the mind and the person. The company said in […]
GE Healthcare, Elekta collaborate to expand precision radiation therapy access
GE Healthcare (NYSE:GE) and Elekta (EKTA-B.ST) recently announced that they have inked a global commercial collaboration agreement. The partnership covers the radiation oncology field. It’s meant to enable the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients. “Access to radiation therapy is a significant challenge in several parts […]
Elekta names permanent CFO
Elekta (STO:EKTA B) today said it has appointed Johan Adebäck as chief financial officer, effective immediately. Adebäck has served as the acting chief financial officer since June of last year. He was previously the group treasurer of the company since 2004, where he was responsible for treasury, taxes, customer financing, operations accounting and customer credit risk. […]
Elekta wins FDA approval for diffusion-weighted images
Elekta (STO:EKTA B) today announced that it received FDA 510(k) premarket notification for its diffusion-weighted MR images from the Elekta Unity. The clearance allows the images to be interpreted by a trained physician. With the new FDA clearance, the system can be used for the biologic assessment of tumor response during therapy. Diffusion-weighted MR images (DWI) […]
Elekta buys treatment planner ProKnow Systems
Elekta (STO:EKTA B) said today that it acquired ProKnow Systems for an undisclosed amount in a move toward cloud-based solutions for advanced radiation therapy. Sweden-based Elekta will have access to ProKnow’s products, namely the ProKnow DS, to offer the cloud-based analytics systems and standardize its practices. The ProKnow DS is designed to allow for analysis of […]
